HHiring Reality
← Vaxcyte

Senior Manager, Commercial MSAT, Polysaccharide

Vaxcyte
Location
San Carlos, California, United States
Posted
2 months ago
Department
Global MSAT
Salary
$165,000 – $193,000
What they actually want (must-haves)
  • Degree(s) in Chemical or Biochemical Engineering, Chemistry, Biochemistry, or related discipline
  • 5+ years of relevant experience for Ph.D., 8+ years for M.S./M.A., or 12+ years for B.S./B.A.
  • Experience in development, tech transfer, scale-up or production of polysaccharide/protein conjugate vaccines
  • Extensive experience in biologic production processes, including bacterial fermentation, recovery, and purification
  • Experience in MSAT or Process Development in matrixed team roles
  • Excellent organization, problem solving and strategic planning skills
Nice to have
  • Experience with Raman spectroscopy and off-gas analyzers
  • Experience with data visualization tools and techniques
  • An entrepreneurial and creative approach to developing new, innovative ideas
What the job really is

The Senior Manager, Commercial MSAT for Polysaccharides will oversee the launch readiness and commercial supply of polysaccharides for glycoconjugate vaccines. This role involves coordinating technical launch planning, regulatory filings, and cross-functional collaboration to ensure successful commercialization and lifecycle management of products. The position also requires effective communication of scientific and commercial processes to stakeholders and regulatory agencies.

Benefits
  • Competitive compensation package
  • Comprehensive benefits
  • Equity component
Things to weigh
  • Remote work arrangement available
  • Salary range provided only for SF Bay Area; non-California locations may vary
  • 10-30% travel required
  • No specific mention of company culture or team dynamics
Job score3.2/5
Benefits2/5
Freshness1/5
Career value4/5
Role clarity4/5
Pay transparency5/5

Applying to Vaxcyte?

See how your résumé matches this role — and tailor it from what actually gets interviews.